Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 7:35 AMFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
Roche wants to expand diabetes business, not sell it supriya kashyap kashyap2 Feb 2017 5:57 AMRoche is looking to expand its $2 billion-per-year diabetes business, not sell it or spin it off.Diagnostics division head Roland Diggelmann dismissed...